Showing 1851-1860 of 3134 results for "".
- AAD 2026: CO2 Laser Resurfacing Linked to Transient Microbiome Shiftshttps://modernaesthetics.com/news/aad-2026-co2-laser-resurfacing-linked-to-transient-microbiome-shifts/2486399/New findings presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, provide insight into dynamic microbiome changes following ablative CO2 laser resurfacing and their relationship to wound healing. In this monocentric, double-blind, rando
- AAD 2026: Oral Supplement Shows Gains in Hair Strength, Collagen VIIhttps://modernaesthetics.com/news/aad-2026-oral-supplement-shows-gains-in-hair-strength-collagen-vii/2486396/New data presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, evaluated a nutraceutical approach to improving hair strength through collagen VII upregulation and mechanical resistance outcomes. The study assessed a daily oral supplement containing turmer
- AAD 2026: Revance to Showcase Expanding Aesthetics Portfoliohttps://modernaesthetics.com/news/aad-2026-revance-to-showcase-expanding-aesthetics-portfolio/2486383/Revance Therapeutics Inc. announced it will showcase its expanding portfolio of aesthetics, regenerative medicine, and consumer skincare products at the 2026 American Academy of Dermatology (AAD) Annual Meeting, scheduled for March 26–31 in Denver, Colorado. The company plans a series of in-booth
- AAD 2026: Acclaro to Highlight Expanding Clinical Uses of UltraClear 2910 nm Fiber Laserhttps://modernaesthetics.com/news/aad-2026-acclaro-to-highlight-expanding-clinical-uses-of-ultraclear-2910-nm-fiber-laser/2486381/Emerging clinical data on Acclaro’s UltraClear® 2910 nm fiber laser is set to be presented during multiple sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado from March 26 through 31. The technology, a cold ablative fiber lase
- Lynch Regenerative Medicine Expands PDGF Portfolio With GEM 21S® Distribution Agreementhttps://modernaesthetics.com/news/lynch-regenerative-medicine-expands-pdgf-portfolio-with-gem-21s-distribution-agreement/2486379/Lynch Regenerative Medicine, LLC (LRM) announced a definitive distribution agreement with Lynch Biologics, a Geistlich North America company, to commercialize GEM 21S®, an FDA-approved recombinant human platelet-derived growth factor (rhPDGF-BB) product, to licensed healthcare providers in the Un
- FDA Approves Restylane Contour for Temple Hollowing Correctionhttps://modernaesthetics.com/news/fda-approves-restylane-contour-for-temple-hollowing-correction/2486354/Galderma announced that the U.S. Food and Drug Administration (FDA) has approved Restylane® Contour™ for the correction of temple hollowing in patients aged 21 years and older, expanding its indications beyond cheek augmentation and midface contour deficiencies. The approval enables clinicians to
- New Skin Quality Index Aims to Align Patient–Provider Communication in Aestheticshttps://modernaesthetics.com/news/new-skin-quality-index-aims-to-align-patientprovider-communication-in-aesthetics/2486112/Allergan Aesthetics, an AbbVie company, announced the launch of the Skin Quality Index (SQI), a new framework designed to standardize how patients and health care providers discuss skin quality during aesthetic consultations. The initiative is supported by global research published in Dermato
- Survey: 53% of Americans Would Sacrifice Everyday Spending for Aesthetic Treatmentshttps://modernaesthetics.com/news/survey-53-of-americans-would-sacrifice-everyday-spending-for-aesthetic-treatments/2486047/More than half of Americans say they would sacrifice everyday spending to afford non-surgical aesthetic procedures, according to a new national survey commissioned by LaserAway and conducted by Morning Consult among 2,202 US adults in February 2026. The findings highlight shifting consumer attitu
- Allergan Aesthetics Panel: Medical Weight Loss Fuels New Aesthetic Conversationshttps://modernaesthetics.com/news/allergan-aesthetics-panel-medical-weight-loss-fuels-new-aesthetic-conversations/2485952/Experts at Allergan Aesthetics’ “Navigating the New Era of Patient Needs” virtual event highlighted how GLP-1 receptor agonists (GLP-1 RAs) are changing facial aesthetic concerns, patient education, and treatment sequencing. Th
- Adipocytes Emerge as Central Drivers of Skin Aging in New Reviewhttps://modernaesthetics.com/news/adipocytes-emerge-as-central-drivers-of-skin-aging-in-new-review/2485879/A recent review in Biogerontology reframes skin aging by positioning adipocytes—particularly dermal white adipose tissue (dWAT)—as central regulators of age-related cutaneous change. Traditionally, skin aging has been attributed to epidermal and dermal alterations, including keratinocyte